XERS

Xeris Biopharma Holdings, Inc.

A Chicago-based biopharmaceutical company that turns hard-to-inject medicines into stable, ready-to-use shots. Its brands include Gvoke, a liquid glucagon that treats dangerously low blood sugar in people with diabetes, plus Keveyis and Recorlev for rare conditions. Founded in 2005, its name comes from the Greek word for "dry," reflecting its water-free (non-aqueous) formulation technology that keeps drugs stable without the fuss of mixing before use.

Recent Activity

Show $

2021Q3

1 sell

ArrowMark PartnersEXIT

-1.82M shares

ArrowMark PartnersEXIT

-1.82M shares

2021Q2

1 sell

ArrowMark PartnersTRIM

-65.6K shares(-3.5%)

ArrowMark PartnersTRIM

-65.6K shares(-3.5%)

2021Q1

1 sell

ArrowMark PartnersTRIM

-101.2K shares(-5.1%)

ArrowMark PartnersTRIM

-101.2K shares(-5.1%)

Loading more activity...